|
1
|
Yaksi N, Teker AG and Imre A: Long COVID
in hospitalized COVID-19 patients: A retrospective cohort study.
Iran J Public Health. 51:88–95. 2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Göktepe ME, Atayoğlu AT, Khan H and Öztürk
O: Health problems accompanying the call for ‘stay at-home’ during
the pandemic. J Health Systems Policies. 3:85–96. 2021.
|
|
3
|
Dhama K, Nainu F, Frediansyah A, Yatoo MI,
Mohapatra RK, Chakraborty S, Zhou H, Islam MR, Mamada SS, Kusuma
HI, et al: Global emerging Omicron variant of SARS-CoV-2: Impacts,
challenges and strategies. J Infect Public Health. 16:4–14.
2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Miteva D, Kitanova M, Batselova H, Lazova
S, Chervenkov L, Peshevska-Sekulovska M, Sekulovski M, Gulinac M,
Vasilev GV, Tomov L and Velikova T: The end or a New Era of
development of SARS-CoV-2 virus: Genetic variants responsible for
severe COVID-19 and clinical efficacy of the most commonly used
vaccines in clinical practice. Vaccines (Basel).
11(1181)2023.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Saunders-Hastings PR and Krewski D:
Reviewing the history of pandemic influenza: Understanding patterns
of emergence and transmission. Pathogens. 5(66)2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Teker AG, Emecen AN, Girgin S,
Şimşek-Keskin H, Şiyve N, Sezgin E, Başoğlu E, Yıldırım-Karalar K,
Appak Ö, Zeka AN, et al: Epidemiological characteristics of
COVID-19 cases in a university hospital in Turkey. Klimik Derg.
341:61–68. 2021.
|
|
7
|
Ünal İ, Güçlüoğlu Ç and Bozdemir N:
COVID-19 in the world and in Turkey: Epidemiologic data. Arch Med
Rev J. 29:2–10. 2020.
|
|
8
|
Nikpouraghdam M, Jalali Farahani A,
Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, Sepandi M, Jafari
NJ, Izadi M, Qazvini A, et al: Epidemiological characteristics of
coronavirus disease 2019 (COVID-19) patients in IRAN: A single
center study. J Clin Virol. 127(104378)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Özkan E: The relationship between COVID-19
age, gender, obesity and mortality. J Soc Humanities Administrative
Sci. 7:293–296. 2021.
|
|
10
|
Arac E, Solmaz I, Akkoc H, Donmezdıl S,
Karahan Z, Kaya S, Mertsoy Y, Yıldırım MS, Ekin N, Araç S, et al:
Association between the Rh blood group and the COVID-19
susceptibility. Int J Hematol Oncol. 30:81–86. 2020.
|
|
11
|
Ray JG, Schull MJ, Vermeulen MJ and Park
AL: Association between ABO and rh blood groups and Sars-Cov-2
infection or severe COVID-19 illness: A population-based cohort
study. Ann Intern Med. 174:308–315. 2021.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Okuyucu M, Ozturk O, Atay MH, Taha Güllü
Y, Temocin F and Terzi O: Clinical evaluation of patients with
COVID-19 within the framework of comorbidities. Med Bull Sisli
Etfal Hosp. 56:311–317. 2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z,
Xiang J, Wang Y, Song B, Gu X, et al: Clinical course and risk
factors for mortality of adult inpatients with COVID-19 in Wuhan,
China: A retrospective cohort study. Lancet. 395:1054–1062.
2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Xiong S, Liu L, Lin F, Shi J, Han L, Liu
H, Jiang Q, Wang Z, Fu W, Li Z, et al: Clinical characteristics of
116 hospitalized patients with COVID-19 in Wuhan, China: A
single-centered, retrospective, observational study. BMC Infect
Dis. 20(787)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Rehm J, Kilian C, Ferreira-Borges C,
Jernigan D, Monteiro M, Parry CDH, Sanchez ZM and Manthey J:
Alcohol use in times of the COVID 19: Implications for monitoring
and policy. Drug Alcohol Rev. 39:301–304. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhang JJ, Dong X, Cao YY, Yuan YD, Yang
YB, Yan YQ, Akdis CA and Gao YD: Clinical characteristics of 140
patients infected with SARS-CoV-2 in Wuhan, China. Allergy.
75:1730–1741. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y and
Zuo W: Single-cell RNA expression profiling of ACE2, the receptor
of SARS-CoV-2. Am J Respiratory Crit Care Med. 202:756–759.
2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chick J: Alcohol and COVID-19. Alcohol
Alcohol. 55:341–342. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Barbosa C, Cowell AJ and Dowd WN: Alcohol
consumption in response to the COVID-19 pandemic in the United
States. J Addict Med. 15:341–344. 2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Çerçi ÜÖ, Canöz N and Canöz K: The use of
social media as an information tool during the COVID-19 crisis.
Selcuk Un. SOS. Bil. Ens. Der. 44:184–198. 2020.
|
|
21
|
Jones SE, Maisha FI, Strausz SJ, Cade BE,
Tervi AM, Helaakoski V, Broberg ME and Lammi V: FinnGen. Lane JM,
et al: The public health impact of poor sleep on severe COVID-19,
influenza and upper respiratory infections. medRxiv: Feb 17, 2022.
doi: 10.1101/2022.02.16.22271055.
|
|
22
|
Herbec A, Brown J, Jackson SE, Kale D,
Zatoński M, Garnett C, Chadborn T and Shahab L: Perceived risk
factors for severe Covid-19 symptoms and their association with
health behaviours: Findings from the HEBECO study. Acta Psychol
(Amst). 222(103458)2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Souza TC, Oliveira LA, Daniel MM, Ferreira
LG, Della Lucia CM, Liboredo JC and Anastácio LR: Lifestyle and
eating habits before and during COVID-19 quarantine in Brazil.
Public Health Nutr. 25:65–75. 2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kahriman HE, Coşkun F and Yılmaz F: The
relationship between eating habits and some habits and catching
Covid-19 during the Covid-19 outbreak in Thrace Region. J Hum Sci.
19:162–184. 2022.
|
|
25
|
Moghadas SM, Vilches TN, Zhang K, Wells
CR, Shoukat A, Singer BH, Meyers LA, Neuzil KM, Langley JM,
Fitzpatrick MC, et al: The impact of vaccination on coronavirus
disease 2019 (COVID-19) outbreaks in the United States. Clin Infect
Dis. 73:2257–2264. 2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Liu X, Shaw RH, Stuart ASV, Greenland M,
Aley PK, Andrews NJ, Cameron JC, Charlton S, Clutterbuck EA,
Collins AM, et al: Safety and immunogenicity of heterologous versus
homologous prime-boost schedules with an adenoviral vectored and
mRNA COVID-19 vaccine (Com-COV): A single-blind, randomised,
non-inferiority trial. Lancet. 398:856–869. 2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Hillus D, Schwarz T, Tober-Lau P,
Vanshylla K, Hastor H, Thibeault C, Jentzsch S, Helbig ET, Lippert
LJ, Tscheak P, et al: Safety, reactogenicity, and immunogenicity of
homologous and heterologous prime-boost immunisation with ChAdOx1
nCoV-19 and BNT162b2: A prospective cohort study. Lancet Respir
Med. 9:1255–1265. 2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Schmidt T, Klemis V, Schub D, Mihm J,
Hielscher F, Marx S, Abu-Omar A, Schneitler S, Becker SL and
Gärtner BC: Immunogenicity and reactogenicity of a heterologous
COVID-19 prime-boost vaccination compared with homologous vaccine
regimens. medRxiv: June 15, 2021. doi:
10.1101/2021.06.13.21258859.
|
|
29
|
Demir Ş and Apaydın H: The relationship
between catching COVID-19 infection in healthcare workers and
keeping cats and dogs at home. Maltepe Med J. 12:71–73. 2020.
|
|
30
|
Yüksel A: The importance of using personal
protective equipment (PPE) in health services. ASHD. 19:44–50.
2021.
|
